In our study, using the breast cancer criteria, IHC 2+ or 3+ expression was found in 15% of cases, more than a half of which (8.3%) showed a true HER2 positivity (IHC 3+ expression or FISH amplification). This evidence concerns the gene ERBB2 and breast cancer.